This study aimed to assess the effect of unroasted, dark and very dark roasted coffee on obesity and metabolic disorders in obese rats. All coffee samples significantly reduced weight gain (∼17%) compared to obese control. Coffee reduced glucose levels (∼17%) upon a glucose tolerance test in all cases compared to the control, while fasting glucose only decreased (∼26%) with very dark coffee. Insulin levels and insulin resistance significantly decreased (∼77% and 65% respectively) with all coffee samples compared to the control. Unroasted and dark roasted coffee decreased triglycerides (∼21% and ∼ 11%, respectively), and unroasted coffee also reduced free fatty acids (∼43%) and adipocyte size. Coffee decreased liver steatosis (∼55%) and Caspase-3 levels (∼27%), regardless of the roasting degree. Overall, coffee plays a positive role in restraining obesity and related metabolic disorders but, depending on the metabolic pathway and relevant marker, an effect of roasting could be either found or not.
